Sareum Holdings Plc - Company Profile
Powered by 
All the sales intelligence you need on Sareum Holdings Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sareum Holdings Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sareum Holdings Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sareum Holdings Plc (Sareum) is focused on developing next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company’s strengths lie in its lead candidate, SDC-1801 and SRA737, and strategic collaborations and partnerships. However, its history of operating losses remains a concern. Despite this, the expanding market for cancer treatments, growth initiative, and Sareum’s promising product pipeline present potential growth opportunities. On the other hand, intense competition, stringent regulations, and rapid technological advancements pose significant challenges that could impact the company’s growth and profitability in the future.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer